Top Banner
THYROTOXICOSIS Presented by: Tanvi Singla
49
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Thyrotoxicosis

THYROTOXICOSIS

Presented by:Tanvi Singla

Page 2: Thyrotoxicosis

Thyrotoxicosis “clinical syndrome that results when

tissues are exposed to high levels of circulating thyroid hormones.”

Hyperthyroidism Other causes like excessive ingestion of thyroxine, release of hormone in ovarian tumors

Page 3: Thyrotoxicosis
Page 4: Thyrotoxicosis

CLINICAL TYPES

Primary thyrotoxicosis (Grave’s disease)

Secondary thyrotoxicosis (Toxic nodular goitre)

Solitary toxic nodule Hyperthyroidism due to rarer

causes

Page 5: Thyrotoxicosis

DIFFUSE TOXIC GOITRE

Grave’s disease (S/S & diffuse vascular goitre appears simultaneously)

Primary thyrotoxicosis 8 times more common in females Hyperthyroidism more severe than secondary Cardiac failure rare

Page 6: Thyrotoxicosis

FEATURES: FEMALE

Female with strong family predisposition (50%)

Extra thyroidal manifestation Middle or young age (30-50 yr) Autoimmune disorder (evidence :demonstration

of TSH R auto – antibodies in the circulation)

human Leukocyte antigen(HLA) and T- lymphocyte may contribute

Enlargement of gland is diffuse.

•Pretibial myxoedema• Proximal myopathy• Acropachy• Ophthalmoplegia

Page 7: Thyrotoxicosis

PATHOGENESIS : autoimmune

Page 8: Thyrotoxicosis

Acini lined flattened cuboidal epithelium, filled with homogenous colloid

Hyperplasic empty acini, which are lined by high columnar epithelium

Page 9: Thyrotoxicosis

C/F:

Most significant being:

weight loss despite good appetite

tiredness

heat intolerance Others being:

emotional instability

palpitations

diarrhoea

Page 10: Thyrotoxicosis

EXAMINATION GPE: underweight

Thyroid gland:

Page 11: Thyrotoxicosis

Site : Swelling in the lower part of the front of the neck.

Size : slight to moderate enlargement.

Shape : symmetrical.

Surface: smooth.

Skin overlying: is warm.

Special character : moves up & down with deglutition.

Consistency : soft or firm

Edge: well defined.

Pulsations & thrills : are detected usually at the upper poles

Page 12: Thyrotoxicosis

CNS signs

Insomnia Tremors of tongue and outstretched

hands Agitation Exaggerated reflexes

Page 13: Thyrotoxicosis

Cutaneous Changes

Moist warm extremities Profuse sweating & flushed face Falling of hairs Clubbing of fingers & toes Soft and brittle nails

Page 14: Thyrotoxicosis

Pretibial myxoedema B/L, non pitting edema, ± a/w

clubbing aka thyrotoxic dermopathy Seen in thyrotoxicosis pt. treated

with surgery or antithyroid drugs Always a/w exophthalmos Cause : deposition of myxomatous

tissue(GAG’s) mainly in pretibial region

Skin – dry coarse and swelling due to obliterated lymphatics by mucin

Page 15: Thyrotoxicosis

CVS

More in elderly PULSE

Rate : Sleeping pulse up to 100 – 120/ min Character : water - hammer character

Rhythm: cardiac arrythmias are superimposed on sinus tachycardia as disease progresses.

Page 16: Thyrotoxicosis

Stages of development of cardiac arrythmias in thyrotoxicosis

Multiple extrasystoles Paroxymal atrial tachycardia Paroxysmal atrial fibrillation Persistent atrial fibrillation

(non responsive to digoxin)

Page 17: Thyrotoxicosis

(V) Eye manifestations :

A. Exophthatmos ( > 50 % of cases ) :

TYPES :

a)Apparent ( mild = false) exophthalmos : widening of the palpebral fissure due to spasm of Muller's muscle.

Page 18: Thyrotoxicosis

b)True exophthalmos : actual protrusion of the eyeballs.

It is an autoimmune disease

Infiltration of retro bulbar tissue with inflammatory cells & fluids with varying degree of spasm of upper eyelid as LPS is partly innervated by symapthetic fibresProbably due to cross- reaction of thyroid antigen & eye (Schwartz )

C.T showing infiltration of Retro bulbar spacesTrue exophthalmos

With widdened palpebral apperture and

clearly seen sclera

Page 19: Thyrotoxicosis
Page 20: Thyrotoxicosis

Classification of eye changes in Graves’ disease

Class Definition

0 No signs or symptoms.

1 Only signs, no symptoms. (Signs limited to

upperlid retraction, stare, lid lag.)

2 Soft tissue involvement (s/s).

3 Proptosis

4 Extraocular muscle involvement(diplopia)

5 Corneal involvement.

6 Sight loss (optic nerve involvement).

Severe cases are marked by pappiloedema and corneal ulceration referred to as malignant exophthalmos

Page 21: Thyrotoxicosis

Spasm and retraction usually disappears when hyperthyroidism is controlled – B adrenergic drugs

Sleeping propped up and lateral tarsorrhaphy help protect the eye

Prednisolone – improvement has been reported….intraorbital not preferred.

When the eye is in danger…orbital decompression reqd

Page 22: Thyrotoxicosis

Toxic nodular goitre Simple, nodular goitre

present for a long time before the hyperthyroidism

Middle aged or elderly Eye symptoms rare Usually nodules are

inactive and interthyroid tissue is overactive

If 1 or more nodules are active – hyperthyroidism is due to autonomous tissue

Page 23: Thyrotoxicosis

Toxic nodule

Solitary overactive nodule Autonomous Hypertrophy not due to

TSH-Rab Normal surrounding thyroid

tissue is inactive due to suppressed TSH secretion bcoz of high , level of circulating hormones

Page 24: Thyrotoxicosis
Page 25: Thyrotoxicosis

TREATMENTNON SPECIFIC – Rest and Sedation.

SPECIFIC – Medical intervention

Surgical intervention

Radioiodine

Page 26: Thyrotoxicosis

ANTI – THYROID DRUGS Carbimazole, Propyluracil, Methimazole B – adrenergic blockers – proranolol,

nadolol Iodides – dec vascularity of the gland

only used as immediate preoperative measure

Drugs help maintain euthyroid state for a long time in hope of spontaneous remission

Block Cvs

effects

Page 27: Thyrotoxicosis

Regime Start with 10mg carbimazole- 3 or 4 times a day

…. Latent interval – 2 weeks

When pt. becomes euthyroid, decrease the dose to 5mg- 2 to 3 times a day for 6 to 24 months

Alternative regime- BLOCK AND REPLACEMENT THERAPY

Inhibit all T3 T4 production with high dose and then give maintainence dose of 0.1 – 0.15mg of thyroxine daily

decreased risk of iatrogenic thyroid insufficiency and less follow up required

Page 28: Thyrotoxicosis

Adv : no surgery and no use of radioactive

Disadv: prolonged t/t and failure rate about 50%.

aplastic anemia and agranulocytosis Poor prognosis: large gland size,

severity of disease nad TSH-Rab levels

Page 29: Thyrotoxicosis

RADIO-IODINE Destroys thyroid cells Reduces mass of thyroid tissue below a

critical level Slow response.. substantial

improvement expected in 8 – 12 wks.. If not repeat dose

Higher dose – thyroid failure in 6mnths Lower dose result in insufficiency Due to sublethal damage to cells not

damaged by t/t

Page 30: Thyrotoxicosis

SURGERY Indicated in- severe diffuse toxic goitre

- toxic nodular goitre with overactive

internodular tissue

-toxic nodule Cures by reducing overactive mass Subtotal thyroidectomy- long term followup Total or near total thyroidectomy- immediate

thyroid failure with life long thyroxine replacement… SIMPLIFIES FOLLOW UP

Page 31: Thyrotoxicosis

Adv: Goitre is removed, cure is rapid and cure rate is high if surgery has been adequate

Disadv: recurrence in 5% cases

risk of permanent hypothyroidism

nerve injury

young women – cosmetic issues

Page 32: Thyrotoxicosis

Structure

Each lobePear shaped2 *1*1 inches

Its apex lies atLevel of oblique lineOf thyroid cartilage& base reach 5th. Or 6th. Tracheal

ring

Isthmus lies on2nd. ,3rd. ,4th ,Tracheal rings

Pyramidal lobeIt is connected to hyoid bone

By fibrous band ( levator glandulae )

thyroid

2 capsules :*true C.T. capsule around gland*false outer capsule from pretracheal fascia

Pretracheal fascia

Page 33: Thyrotoxicosis

1- arterial :

Blood supply

• superior thyroid artery• Branch from E.C.A..

– Inferior thyroid artery– Branch from thyrocervical trunk– Which is branch of 1st. Part of subclavian

OthersThyroid artery from aorta ( may be absent )

Accessory tracheal & esophageal braches

Page 34: Thyrotoxicosis

2- venous :

Superior thyroid veindrain to I.J.V.

middle thyroid veindrain to I.J.V.

inferior thyroid veinsdrain to left innominate vein

The middle thyroid veinIs the shortest soit is the

1st To be ligated

Page 35: Thyrotoxicosis

Superior laryngeal nerve

internal laryngeal nerve Sensory to m.m of

Larynx above vocal cords

external laryngeal nerve

Motor to cricotyroidMuscle

Injury causes voice weaknessIt is closely related

To Superior thyroid artery

Right R.L.N.Turns around 1st. PartOf subclavian artery

Left R.L.N.Turns around arch of

aorta

Both supply all Intrinsic musclesOf larynx except (cricothyroid )

& m.m below vocal cordsInjury causes vocal cord paralysis

Page 36: Thyrotoxicosis

Surgical anatomy From superficial to deep:

SkinPlatysma (a muscle in superficial fascia

of neck)Investing layer of deep cervical fasciaPre-tracheal layer of deep cervical

fasciaStrap muscles of neck (thin flat

muscles)

Page 37: Thyrotoxicosis

Preoperative preparation

Make patient euthyroid

CARBIMAZOLE regime (8-12wks)

Alternate: B adrenergic blocking drugs

abolish clinical manifest. of toxic state

propranolol(40mgTDS) or nadolol(160mg OD)

rapid response.. Operation can be arranged within few days

continue therapy for 7 days postoperatively

Page 38: Thyrotoxicosis

Investigations

Full blood count (CBC) Serum Urea, Electrolytes, Creatinine Thyroid Function tests Laryngoscopy Thyroid antibodies Serum calcium estimation Radio-iodine (99mTc / 131I) scan of thyroid

Page 39: Thyrotoxicosis

INFORMED CONSENT FOR THE SURGERY IS

ESSENTIAL

Page 40: Thyrotoxicosis

Technique

GA with endotracheal intubation Pt. is supine with table tilted at 15° at the

head end to reduce venous engorgement (reverse trendelenburg)

Sand bag placed transversely under the shoulder

Neck extended Apply tension to skin, platysma and

strap msls for easy dissection.

Page 41: Thyrotoxicosis

Curved skin incision made midway between notch of thyroid cartilage and suprasternal notch

Flaps of skin, s/c, platysma raised upwards to superior thyroid notch and downwards to suprasternal notch

Page 42: Thyrotoxicosis

Exposing the gland

Investing fascia divided in the midline Strap msls divided only if large area to be

exposed Sternohyoid msl is mobilised off the thyroid

lobe taking care to stay close to msl and outside capsule

Pretracheal fascia opened Gland is exposed

Page 43: Thyrotoxicosis

Dealing with vessels Arteries before veins (to prevent venous

engorgement) Vessels clamped, divided and ligated Superior thyroid artery ligated close to the

upper pole of the gland. This is to prevent damage to external

laryngeal nerve.

Page 44: Thyrotoxicosis

Inferior thyroid artery is similarly dealt with faraway from the lower pole of the gland

This is to safeguard recurrent laryngeal nerve.

They are not routinely ligated to preserve parathyroid function

Then superior, middle and inferior thyroid veins are dealt with in a similar manner.

Page 45: Thyrotoxicosis

i

SUBTOTAL THYROIDECTOMY

TRANSECTED ISTHMUSLobe resected from medial and lateral surface to produce a V shaped suture

4-5gm left

In total thyroidectomy , complete excision of gland with autoimplantation of parathyroid gland

Page 46: Thyrotoxicosis

Parathyroid glands

Identified by careful inspection If inadvertently or unavoidbly excised or

devasularised Should be fragmented and auto-

transplanted immediately within sternoclenomastoid muscle

Page 47: Thyrotoxicosis

Absolute hemostasis secured by ligation of individual vessels and by suture of thyroid remnants to tracheal fascia

Pretracheal msls and cervical fascia are sutured and wound closed

Page 48: Thyrotoxicosis

Complications Hemorrhage Respiratory obstruction Recurrent laryngeal nerve paralysis-Hoarseness

of voice Hypocalcemic tetany (due to accidental removal

of parathyroid glands during total thyroidectomy) Wound infection: This may manifest after 48

hours of surgery Thyroid insufficiency Thyrotoxic crisis Hypertrophic / Keloid scar Stitch granuloma

Page 49: Thyrotoxicosis

Post operative care Transient hypocalcemia – oral Ca+2

maybe necessary….if severe then 10ml IV Ca+2 gluconate 10% given

Screen parathyroid insufficiency – serum Ca+2 measured 4-6wks after operation

Recurrent thyrotoxicosis common – lifelong follow up